|
A Multicenter, longitudinal, interventional not pharmacological study to investigate the role of ADA SNPs and other potential biomarkers affecting lymphopenia, in subjects with Relapsing Multiple Sclerosis treated with an immune-reconstitution therapy (2-CdA) according to clinical practice.
|